Agilent Technologies, Inc. (A)

Market Cap	48.08B +22.4%
Revenue (ttm)	7.37B +8.6%
Net Income	1.44B +18.0%
EPS	5.07 +18.4%
Shares Out	281.93M
PE Ratio	33.16
Forward PE	25.60
Dividend	$1.02 (0.60%)
Ex-Dividend Date	Oct 6, 2026

Volume	1,537,412
Open	168.57
Previous Close	168.17
Day's Range	168.57 - 172.19
52-Week Range	108.35 - 177.05
Beta	1.21
Analysts	Buy
Price Target	178.50 (+4.67%)
Est. Earnings	Nov 23, 2026

About A

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnosti...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Nov 18, 1999
• Employees: 18,100
• Stock Exchange: NYSE
• Ticker Symbol: A
• Website: https://www.agilent.com

Financial Performance

In fiscal year 2025, Agilent Technologies's revenue was $6.95 billion, an increase of 6.73% compared to the previous year's $6.51 billion. Earnings were $1.30 billion, an increase of 1.09%.

Analyst Summary

According to 22 analysts, the average rating for A stock is "Buy." The 12-month stock price target is $178.5, which is an increase of 4.67% from the latest price.

Price Target

$178.5

(4.67% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Oct 10, 2026

Data Sources Report a data error